| Bioactivity | Tivumecirnon (FLX475) is a potent CCR4 antagonist that blocks regulatory T cells that interfere with effective antitumor immune responses and has antitumor activity[1]. | ||||||||||||
| Name | Tivumecirnon | ||||||||||||
| CAS | 2174938-78-2 | ||||||||||||
| Formula | C24H27Cl2F3N6O | ||||||||||||
| Molar Mass | 543.41 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Hilary Plake BECK, et al. Chemokine receptor modulators and uses thereof. WO2018022992. |
Tivumecirnon
CAS: 2174938-78-2 F: C24H27Cl2F3N6O W: 543.41
Tivumecirnon (FLX475) is a potent CCR4 antagonist that blocks regulatory T cells that interfere with effective antitumor
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.